Active Stocks
Tue May 20 2025 15:45:39
  1. Tata Steel share price
  2. 158.65 0.73%
  1. Itc share price
  2. 435.40 0.07%
  1. Reliance Industries share price
  2. 1,425.30 -1.13%
  1. Tata Motors share price
  2. 718.75 -1.43%
  1. Power Grid Corporation Of India share price
  2. 298.00 -2.01%
Business News/Market/Market Stats/    Alembic Pharmaceuticals

ALEMBIC PHARMACEUTICALS SUMMARY

Alembic Pharmaceuticals is trading 5.66% lower at Rs 970.00 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 1018.00 & 962.00. Alembic Pharmaceuticals has given -3.53% in this year & 16.95% in the last 5 days.

 

Alembic Pharmaceuticals has TTM P/E ratio 31.39 as compared to the sector P/E of 24.5. There are 11 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 2 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.

 

The company posted a net profit of 156.9 Crores in its last quarter.

 

Listed peers of Alembic Pharmaceuticals include Gland Pharma (0.97%), Wockhardt (-2.53%), Alembic Pharmaceuticals (-5.66%) etc.

 

Alembic Pharmaceuticals has a 69.67% promoter holding & 30.33% public holding.

FAQs about Alembic Pharmaceuticals

Alembic Pharmaceuticals is trading at 970.00 as on 20 May, 2025 3:59:04 PM. This is -5.66% lower as compared to its previous closing price of 1028.25
The market capitalization of Alembic Pharmaceuticals is 19066.62 Cr as on 20 May, 2025 3:59:04 PM.
The average broker rating on Alembic Pharmaceuticals is Buy. The breakup of analyst rating is given below -
  • 1 analysts have given a strong sell rating
  • 0.00 analysts have given a sell rating
  • 5 analysts have given a hold rating
  • 2 analysts have given a buy rating
  • 3 analysts have given a strong buy rating
The 52 wk high for Alembic Pharmaceuticals is 1296.15 whereas the 52 wk low is 725.60
Alembic Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 31.39
  • Sector P/E: 24.5
  • Dividend Yield: 1.07%
  • D/E ratio: -
Alembic Pharmaceuticals reported a net profit of 583.42 Cr in 2025.
Recommended For You